CMP-001 in Combo With Nivolumab in Stage IIIB/C/D Melanoma Patients With Clinically Apparent Lymph Node Disease
Clinical trial NCT03618641 · COMPLETED
Trial details
- NCT number
- NCT03618641
- Sponsor
- Diwakar Davar
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-08
- Primary completion
- 2020-08-20
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.